Sell Your Surgical Instrument Manufacturing Business to the Right Buyer
Confidential lower-middle-market M&A advisory, verified valuation benchmarks, and institutional acquirer access for Surgical Instrument Manufacturing company owners.
Why Selling a Surgical Instrument Manufacturing Company Demands Industry-Specific M&A Advisory
20+
Years in M&A Advisory
50
States Served Nationwide
$1M–$250M
Revenue Range We Serve
In-House
CPA, Legal, & Capital Advisory
Why Selling a Surgical Instrument Manufacturing Company Demands Industry-Specific M&A Advisory
Operating an established Surgical Instrument Manufacturing business involves producing high-tolerance surgical instruments, managing ISO 13485 quality assurance, sterilization validation, and hospital distribution. Business owners balance day-to-day operational margins with client retention and skilled workforce management. Strategic acquirers actively target companies in this sector because reliable operations generate predictable cash flow and established market share.
Qualified corporate buyers prioritize proprietary surgical instrument designs, ISO 13485 and FDA compliance, recurring hospital and ASC purchasing agreements, and skilled machinists. At Aria Business Advisors, we articulate your operational strengths, recast discretionary earnings, and confidentially market your company to vetted strategic acquirers to secure top valuation multiples.

Who Buys Surgical Instrument Manufacturing Businesses
The Surgical Instrument Manufacturing M&A market is active. Knowing which buyer type fits your business determines how you position it and how much you walk away with.
Strategic Surgical & MedTech OEMs


Healthcare & Industrial Private Equity
MedTech Search Funds & Operators

We run a strictly confidential, controlled process. We screen out window-shoppers so you only engage with well-capitalized, qualified acquirers. Every buyer is rigorously vetted for financial capacity and strategic fit. Your sensitive data is never disclosed without a signed NDA and explicit approval.
Surgical Instrument Manufacturing M&A Valuation Multiples & Benchmark
Aria M&A Transaction Database • Updated for 2026 Transactions
Surgical Instrument Manufacturing operations trade at a median 8.45x EBITDA (typical range: 5.13x – 19.61x) for middle-market platforms, and 4.42x SDE (2.54x – 5.7x) for owner-operated companies, with revenue multiples averaging 2.52x (0.79x – 2.9x).
2026 M&A Market Dynamics
Surgical OEMs and healthcare private equity platforms targeting precision surgical instrument manufacturers with established hospital and ASC distribution.
Peak Valuation Drivers
- ISO 13485 certification
- hospital and ASC GPO contract access
- proprietary surgical tooling
- and recurring disposable/instrument reorders.
Surgical Instrument Manufacturing Businesses We Help Sell
Our team has advised on transactions across the full range of Surgical Instrument Manufacturing and related operations.


How We Sell Your Surgical Instrument Manufacturing Company
A disciplined, fully confidential process that protects your team, customers, and competitive position throughout the transaction.
Valuation
Comprehensive recasting of financial statements, normalization of owner compensation, evaluation of contracted client backlog, and calculation of true adjusted EBITDA.
CIM and Buyer-Facing Materials
Development of a confidential marketing prospectus highlighting operational procedures, customer retention metrics, and middle-management leadership.
Targeted Buyer Outreach
Confidentially presenting the opportunity to qualified strategic consolidators, regional operators, and vetted private equity sponsors under strict non-disclosure agreements.
Negotiation
Structuring competitive purchase agreements to maximize cash at closing, establish clean working capital targets, and protect the seller from post-closing liabilities.
Due Diligence & Closing
Managing quality of earnings audits, client contract novations, regulatory licensing assignments, and escrow disbursements to complete a successful transaction.
Recent Closed M&A Transactions
Frequently Asked Questions
Surgical Instrument Manufacturing companies typically trade at 2.54x to 5.7x SDE for owner-operated firms or 5.13x to 19.61x+ adjusted EBITDA for scaled regional platforms, with premiums paid for verified financial records and repeat client accounts.
Strategic buyers prioritize proprietary surgical instrument designs, ISO 13485 and FDA compliance, recurring hospital and ASC purchasing agreements, and skilled machinists, looking for established operational leadership that can operate without founder dependency.
We structure assignment terms and key employee retention agreements during contract negotiations, ensuring relationships transfer smoothly to the new operating team without alerting clients prematurely.
Most acquirers require a 3 to 12 month transition period where the seller introduces primary corporate contacts, oversees training, and assists with operational handover.
Surgical Instrument Manufacturing enterprises are categorized under NAICS Code 339113 (Surgical Appliance & Supplies Manufacturing) and SIC Code 3842 (Orthopedic, Prosthetic, and Surgical Appliances), which establish official benchmarks for banking appraisals and transaction filings.
What Aria Does Differently for Surgical Instrument Manufacturing Business Owners
There are generalist brokers who will take your listing. Aria runs a process, and for Surgical Instrument Manufacturing business owners, the difference shows up in the final number.
.png?width=60&height=60&name=1175291%201%20(7).png)
We Know Surgical Instrument Manufacturing Valuations
Payer mix stability, provider credentialing, clinical staff retention, and low patient concentration. directly command top acquisition multiples.
.png?width=60&height=60&name=1175291%201%20(2).png)
Strict Confidentiality
Crew uncertainty can damage a deal fast. Our process keeps the sale confidential until you decide to disclose, helping protect operations and staff stability.
.png?width=60&height=60&name=1175291%201%20(4).png)
One Team, Start to Close
CPA, legal, M&A, real estate, and capital raising all under one roof. The same team that values your business manages the transaction through closing.
.png?width=60&height=60&name=1175291%201%20(5).png)
Access to Active Buyers
We work directly with PE-backed platforms, strategic acquirers, and institutional buyers actively acquiring surgical instrument manufacturing companies.
Reviews from Our Clients
Position Your Surgical Instrument Manufacturing Company for the Right Buyer
Aria’s Surgical Instrument Manufacturing business advisory team prepares, markets, and negotiates Surgical Instrument Manufacturing company business sales with institutional and strategic buyers actively acquiring in the space.
We Close Surgical Instrument Manufacturing Business Sales Across the Country
Aria delivers Surgical Instrument Manufacturing M&A advisory services nationwide, with strong transaction activity across the Midwest, Mid-Atlantic, and Southeast, supporting owners in all U.S. markets.
No matter where your company is based, our team delivers nationwide M&A support.
Contact Us to Get Started